Pharmigene, Inc. 7595.TWO Stock
19.6 TWD
{{ price }}
0.000000%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Diagnostics & Research
COUNTRY
Taiwan
Exchange
Taipei Exchange
Market Cap
989.11M TWD
LOW - HIGH [24H]
19.4
-
19.7 TWD
VOLUME [24H]
36K TWD
{{ volume }}
P/E Ratio
0
Earnings per share
-1.11 TWD
Pharmigene, Inc. Price Chart
Pharmigene, Inc. 7595.TWO Financial and Trading Overview
| Pharmigene, Inc. stock price | 19.6 TWD |
| Previous Close | 22.6 TWD |
| Open | 22.4 TWD |
| Bid | 22.4 TWD x N/A |
| Ask | 22.65 TWD x N/A |
| Day's Range | 22.4 - 22.5 TWD |
| 52 Week Range | 13.4 - 23.9 TWD |
| Volume | 11K TWD |
| Avg. Volume | 76.08K TWD |
| Market Cap | 977.96M TWD |
| Beta (5Y Monthly) | 0.051423 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.11 TWD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
7595.TWO Valuation Measures
| Enterprise Value | 796.15M TWD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 7.309082 |
| Price/Book (mrq) | 2.8783422 |
| Enterprise Value/Revenue | 5.95 |
| Enterprise Value/EBITDA | -25.136 |
Trading Information
Pharmigene, Inc. Stock Price History
| Beta (5Y Monthly) | 0.051423 |
| 52-Week Change | 3.43% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 23.9 TWD |
| 52 Week Low | 13.4 TWD |
| 50-Day Moving Average | 22.87 TWD |
| 200-Day Moving Average | 18.91 TWD |
7595.TWO Share Statistics
| Avg. Volume (3 month) | 76.08K TWD |
| Avg. Daily Volume (10-Days) | 86.88K TWD |
| Shares Outstanding | 43.47M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -31.92% |
| Operating Margin (ttm) | -33.22% |
| Gross Margin | 33.42% |
| EBITDA Margin | -23.67% |
Management Effectiveness
| Return on Assets (ttm) | -6.91% |
| Return on Equity (ttm) | -11.83% |
Income Statement
| Revenue (ttm) | 133.8M TWD |
| Revenue Per Share (ttm) | 3.08 TWD |
| Quarterly Revenue Growth (yoy) | 12.69% |
| Gross Profit (ttm) | N/A |
| EBITDA | -31674000 TWD |
| Net Income Avi to Common (ttm) | -42716000 TWD |
| Diluted EPS (ttm) | -0.99 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 195.59M TWD |
| Total Cash Per Share (mrq) | 4.5 TWD |
| Total Debt (mrq) | 9.43M TWD |
| Total Debt/Equity (mrq) | 2.78 TWD |
| Current Ratio (mrq) | 6.75 |
| Book Value Per Share (mrq) | 7.817 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -23466000 TWD |
| Levered Free Cash Flow (ttm) | -19554750 TWD |
Profile of Pharmigene, Inc.
| Country | Taiwan |
| State | N/A |
| City | Taipei |
| Address | No. 17, Ln. 171, Jiuzong Road |
| ZIP | 114 |
| Phone | 886 2 2798 5885 |
| Website | https://www.pharmigene.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Pharmigene, Inc. develops, manufactures, and sells diagnostic tests worldwide. The company primarily develops DNA genetic tests. It also offers molecular diagnostics related products to test adverse drug reactions. The company was founded in 2005 and is headquartered in Taipei, Taiwan.
Q&A For Pharmigene, Inc. Stock
What is a current 7595.TWO stock price?
Pharmigene, Inc. 7595.TWO stock price today per share is 19.6 TWD.
How to purchase Pharmigene, Inc. stock?
You can buy 7595.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Pharmigene, Inc.?
The stock symbol or ticker of Pharmigene, Inc. is 7595.TWO.
Which industry does the Pharmigene, Inc. company belong to?
The Pharmigene, Inc. industry is Diagnostics & Research.
How many shares does Pharmigene, Inc. have in circulation?
The max supply of Pharmigene, Inc. shares is 50.47M.
What is Pharmigene, Inc. Price to Earnings Ratio (PE Ratio)?
Pharmigene, Inc. PE Ratio is now.
What was Pharmigene, Inc. earnings per share over the trailing 12 months (TTM)?
Pharmigene, Inc. EPS is -1.11 TWD over the trailing 12 months.
Which sector does the Pharmigene, Inc. company belong to?
The Pharmigene, Inc. sector is Healthcare.